Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00859014 · ClinicalTrials.gov registry record · Phase 1
Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients
A Phase 1 study of Ischemic Stroke, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT00859014 is a Phase 1 study of Ischemic Stroke that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 25 participants, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00859014, a Phase 1 study of Ischemic Stroke, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to find out if bone marrow treatment (bone marrow aspiration and infusion of stem cells) can be safely used in adults who have recently (within 24-72 hours)suffered an acute ischemic stroke.
Conditions Studied
Interventions
- BIOLOGICAL Autologous Bone Marrow Mononuclear Cells
Study Locations (1)
Texas
- Memorial Hermann Hospital-Medical Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-01 |
| Est. Completion | 2013-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00859014
The ClinicalTrials.gov registry entry for NCT00859014 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (98% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Autologous Bone Marrow Mononuclear Cells is the first listed.
NCT00859014 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00859014 about?
NCT00859014 is a clinical study titled "Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients". The purpose of this research study is to find out if bone marrow treatment (bone marrow aspiration and infusion of stem cells) can be safely used in adults who have recently (within 24-72 hours)suffered an acute ischemic stroke.
What is the current status of trial NCT00859014?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2009-01. Estimated completion is 2013-11.
What conditions does trial NCT00859014 study?
This clinical trial studies the following conditions: Ischemic Stroke.
What interventions are being tested in trial NCT00859014?
The interventions under investigation include: Autologous Bone Marrow Mononuclear Cells (BIOLOGICAL).
Who is sponsoring clinical trial NCT00859014?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00859014 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Verapamil for Neuroprotection in Stroke
RECRUITING · Phase 1
-
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
RECRUITING · Phase 1
-
A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)
ACTIVE NOT RECRUITING · Phase 1
-
A Study of NCS-01 in Patients With Acute Ischemic Stroke
ACTIVE NOT RECRUITING · Phase 1
-
Functional Magnetic Resonance Imaging (fMRI) and Robot-Assisted Practice of Activities of Daily Living
COMPLETED · Phase 1
-
The Capillary Index Score Trial
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.